MOMENTUM 3 IDE Clinical Study Protocol (HM3™)
Trial ID or NCT#
Status
Purpose
The HM3 LVAS is intended to provide hemodynamic support in patients with advanced, refractory left ventricular heart failure; either for short-term support, such as a bridge-to-cardiac transplantation (BTT) or myocardial recovery, or as long-term support, such as destination therapy (DT). The HM3 is intended for use inside or outside the hospital.
Investigator(s)
View on ClinicalTrials.gov